Vanderbilt University Medical Center
Nashville, TN, United States
Dr. Rathmell studies mechanisms that regulate lymphocyte fate and differentiation in inflammatory diseases and cancer. He has an interdisciplinary research program with a focus on genetic and biochemical approaches to discover mechanisms of immunometabolism that drive or influence immune-related diseases. Following a PhD in Immunology at Stanford University and postdoctoral studies at the University of Pennsylvania, his work as faculty at Duke University and Vanderbilt University showed that the metabolism of lymphocytes was dynamically regulated, and that each T cell subset adopts a specific metabolic program that can be targeted to modulate cell function and fate. He joined Vanderbilt in 2015 to direct the Vanderbilt Center for Immunobiology and is Leader for the Vanderbilt Ingram Cancer Center Program in Host-Tumor Interactions. His awards include Scholar of the Leukemia & Lymphoma Society, Bernard Osher Fellow of the American Asthma Foundation, and William Paul Distinguished Innovator of the Lupus Research Alliance.
Metabolic Mechanisms That Control Inflammation and Immune-Related Disorders
Monday, November 13, 2023
12:00 PM – 12:15 PM PT
Disclosure(s): Caribou: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Nirogy: Consultant (Terminated), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Terminated); Sitryx: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
